Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Defining reliable disability outcomes in multiple sclerosis.
LINGO-1 Interacts with the p75 Neurotrophin Receptor in Intracellular Membrane Compartments.
CCR5 knockout suppresses experimental autoimmune encephalomyelitis in C57BL/6 mice.
Cognitive function alone is a poor predictor of health-related quality of life in employed patients with MS: results from a cross-sectional study.
A spring to summer shift of pro-inflammatory cytokine production in multiple sclerosis patients.
Neurogenic lower urinary tract dysfunction in the early disease phase of paediatric multiple sclerosis.
Sphingosine kinase inhibition ameliorates chronic hypoperfusion-induced white matter lesions.
Modeling leukocyte trafficking at the human blood-nerve barrier in vitro and in vivo geared towards targeted molecular therapies for peripheral neuroinflammation.
[Progressive multifocal leukoencephalopathy as a complication of natalizumab therapy].
Evasion of Antiviral Innate Immunity by Theiler's Virus L* Protein through Direct Inhibition of RNase L.
Epitopes of microbial and human heat shock protein 60 and their recognition in myalgic encephalomyelitis.
Treatment of acute optic neuritis and vision complaints in multiple sclerosis.
Alemtuzumab in the treatment of multiple sclerosis.
IFN-β differentially regulates the function of T cell subsets in MS and EAE.
[PET-patterns of cognitive impairment in patients with multiple sclerosis.]
Detecting multiple autoantibodies to diagnose autoimmune co-morbidity (multiple autoimmune syndromes and overlap syndromes): a challenge for the autoimmunologist.
The Wnt Effector Transcription Factor 7-Like 2 Positively Regulates Oligodendrocyte Differentiation in a Manner Independent of Wnt/β-Catenin Signaling.
Ureteral rupture from aberrant Foley catheter placement: A case report.
Brain networks disconnection in early multiple sclerosis cognitive deficits: An anatomofunctional study.
Partial deficiency of sphingosine-1-phosphate lyase confers protection in experimental autoimmune encephalomyelitis.
The Central Role of Neuroscientists under National Socialism.
The Scandinavian paradox revisited: Editorial comment on Berg-Hansen et al. 'High prevalence and no latitude gradient of multiple sclerosis in Norway'.
Synergistic Interactions between Cytokines and AVP at the Blood-CSF Barrier Result in Increased Chemokine Production and Augmented Influx of Leukocytes after Brain Injury.
Assessment of prevalence and pathological response to orthostatic provocation in patients with multiple sclerosis.
Pages
« first
‹ previous
…
513
514
515
516
517
518
519
520
521
…
next ›
last »